Back to Clinical Feed
Try:
Front ImmunolInfectious Disease
Integrative plasma proteomics and myeloid- interferon profiling reveal an AI-validated vascular- endothelial stress signature distinguishing SLE flare from remission in an Indian cohort a discovery – phase study
03 Jun 20266 min read0 viewsJournal Feed
GIST (Key Takeaways)
- Background. Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disorder characterized by unpredictable flares and variable clinical quiescence. Despite validated clinical indices like the British Isles Lupus Assessment Group (BILAG) score, reliable molecular biomarkers for monitoring disease activity remain limited, particularly in underrepresented South Asian populations.
- Weaimed to identify arobust molecular framework to distinguish SLE flares from remission in an Indian cohort. Methods. We conducted a discovery-phase study in an Indian cohort (n=16) stratified by Easy-BILAG scoring.
- Plasma proteomic profiling via LC-MS/MS was integrated with targeted cytokine quantification using the Olink Proximity Extension Assay (PEA). Differential expression and network analyses delineated immune-regulatory, hypoxic-vascular, and myeloid-activation pathways. A Random Forest classifier was trained on selected biomarkers and evaluated using leave-one-out cross-validation (LOOCV), permutation testing, and bootstrapped AUROC confidence intervals, with model interpretability assessed by SHAP values.
Clinical Editorial
Summary
Frontiers in Immunology published a clinical update in Infectious Disease on 03 Jun 2026.
The item focuses on Integrative plasma proteomics and myeloid- interferon profiling reveal an AI-validated vascular- endothelial stress signature distinguishing SLE flare from remission in an Indian cohort a discovery – phase study.
Review the original article for the full source wording and details.
Source Reference
Read the full original publication from the source journal or publisher link below.
Related by Condition/Drug
Front ImmunolRelated by Specialty
Synergizing radiotherapy and immunotherapy for locally advanced gastric cancer: evolving paradigms and future directions
Infectious Disease • 26 Jun 2026
Front ImmunolRelated by Specialty
Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities
Infectious Disease • 26 Jun 2026
Nat ImmunolRelated by Specialty
Airway immune signatures of protection and disease progression in recent human tuberculosis household contacts
Infectious Disease • 24 Jun 2026
Nat ImmunolRelated by Specialty
Diversifying the antibody response to influenza virus with an mRNA-based vaccine
Infectious Disease • 23 Jun 2026
Feed Metadata
Source
Frontiers in Immunology
Category
Infectious Disease
Published
03 Jun 2026
Feed Metadata
Source
Frontiers in Immunology
Category
Infectious Disease
Published
03 Jun 2026